Rugo HS - Search Results

1

Prognostic Factors for Overall Survival in Patients with Hormone Receptor-Positive Advanced Breast Cancer: Analyses From PALOMA-3.

Rugo HS, Cristofanilli M, Loibl S, Harbeck N, DeMichele A, Iwata H, Park YH, Brufsky A, Theall KP, Huang X, McRoy L, Bananis E, Turner NC. Rugo HS, et al. Oncologist. 2021 Aug;26(8):e1339-e1346. doi: 10.1002/onco.13833. Epub 2021 Jun 12. Oncologist. 2021. PMID: 34037282 Free PMC article. Clinical Trial.

2

High-dose chemotherapy (CTM) for breast cancer.

Damon LE, Wolf JL, Rugo HS, Gold E, Zander AR, Cassidy M, Cecchi G, Cohen N, Irwin D, Tracy M, Ries CA, Linker CA. Damon LE, et al. Among authors: rugo hs. Bone Marrow Transplant. 2000 Aug;26(3):257-68. doi: 10.1038/sj.bmt.1702481. Bone Marrow Transplant. 2000. PMID: 10967563 Clinical Trial.

3

Bevacizumab in the treatment of breast cancer: rationale and current data.

Rugo HS. Rugo HS. Oncologist. 2004;9 Suppl 1:43-9. doi: 10.1634/theoncologist.9-suppl_1-43. Oncologist. 2004. PMID: 15178815 Free article. Review.

4

Hormonal therapy for advanced breast cancer.

Rugo HS. Rugo HS. Hematol Oncol Clin North Am. 2007 Apr;21(2):273-91. doi: 10.1016/j.hoc.2007.03.007. Hematol Oncol Clin North Am. 2007. PMID: 17512449 Review.

5

The importance of distant metastases in hormone-sensitive breast cancer.

Rugo HS. Rugo HS. Breast. 2008 Jan;17 Suppl 1:S3-8. doi: 10.1016/S0960-9776(08)70002-X. Breast. 2008. PMID: 18279764 Review.

6

New challenges and opportunities in the management of brain metastases in patients with ErbB2-positive metastatic breast cancer.

Melisko ME, Glantz M, Rugo HS. Melisko ME, et al. Among authors: rugo hs. Nat Clin Pract Oncol. 2009 Jan;6(1):25-33. doi: 10.1038/ncponc1243. Epub 2008 Oct 21. Nat Clin Pract Oncol. 2009. PMID: 18936791 Review.

7

Cost comparison of capecitabine in patients with breast cancer.

Rugo HS, Kohles J, Schulman KL. Rugo HS, et al. Am J Clin Oncol. 2010 Dec;33(6):550-6. doi: 10.1097/COC.0b013e3181c06f94. Am J Clin Oncol. 2010. PMID: 20051811

8

Triple-negative breast cancer: role of antiangiogenic agents.

Greenberg S, Rugo HS. Greenberg S, et al. Among authors: rugo hs. Cancer J. 2010 Jan-Feb;16(1):33-8. doi: 10.1097/PPO.0b013e3181d38514. Cancer J. 2010. PMID: 20164688 Review.

9

The cardiac safety of trastuzumab in the treatment of breast cancer.

Chien AJ, Rugo HS. Chien AJ, et al. Among authors: rugo hs. Expert Opin Drug Saf. 2010 Mar;9(2):335-46. doi: 10.1517/14740331003627441. Expert Opin Drug Saf. 2010. PMID: 20175700 Review.

10

Challenging clinical scenarios: treatment of patients with triple-negative or basal-like metastatic breast cancer.

Greenberg S, Rugo HS. Greenberg S, et al. Among authors: rugo hs. Clin Breast Cancer. 2010 Sep;10 Suppl 2:S20-9. doi: 10.3816/CBC.2010.s.009. Clin Breast Cancer. 2010. PMID: 20805062 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

528 results

Search Page

Filters